DPHARMA+

Serial Number 79262758
Registration 6098329
404

Registration Progress

Application Filed
Jun 3, 2019
Under Examination
Approved for Publication
Dec 10, 2019
Published for Opposition
Dec 10, 2019
Registered
Jul 14, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-07-14)
Due: Jul 14, 2026 323 days

Trademark Image

DPHARMA+

Basic Information

Serial Number
79262758
Registration Number
6098329
Filing Date
June 3, 2019
Registration Date
July 14, 2020
Published for Opposition
December 10, 2019
Cancellation Date
July 16, 2020
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
404
Status Date
Jul 16, 2020

Rights Holder

DERMOPHISIOLOGIQUE S.R.L. SOCIETA' BENEFIT O IN BREVE DERMOPHISIOLOGIQUE S.R.L. SB

99
Address
Vicolo Luigi Pasteur, 120
I-21042 Caronno Pertusella (Varese)
IT

Ownership History

DERMOPHISIOLOGIQUE S.R.L. SOCIETA' BENEFIT O IN BREVE DERMOPHISIOLOGIQUE S.R.L. SB

Original Applicant
99
IT

DERMOPHISIOLOGIQUE S.R.L. SOCIETA' BENEFIT O IN BREVE DERMOPHISIOLOGIQUE S.R.L. SB

Owner at Publication
99
IT

DERMOPHISIOLOGIQUE S.R.L. SOCIETA' BENEFIT O IN BREVE DERMOPHISIOLOGIQUE S.R.L. SB

Original Registrant
99
IT

Legal Representation

Attorney
Anthony P. Venturino

USPTO Deadlines

Next Deadline
323 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-07-14)
Due Date
July 14, 2026
Grace Period Ends
January 14, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Jul 30, 2020 DENC E NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Loading...
Jul 30, 2020 DETH P DEATH OF INTERNATIONAL REGISTRATION Loading...
Jul 14, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 4, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 4, 2020 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Jan 8, 2020 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Dec 10, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 10, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 6, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 6, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 6, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 5, 2019 ALIE A ASSIGNED TO LIE Loading...
Oct 30, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 5, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Sep 13, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 13, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 31, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Aug 30, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 20, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 16, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 11, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Design Mark
The mark consists of the letter "D" in upper case stylized bold font. The upper left portion of the letter "D" incorporates three small squares positioned in a horizontal downward pattern. The letter "D" is followed by the word "PHARMA" in smaller sized upper case font followed by a plus symbol.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
DPHARMA PLUS

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"